Çelik İE,Öztürk S,Yarlıoğlu M,Barutçu O,Akgün O,Duran M .2023 .The Association Between Atherogenic Index of Plasma and NoReflow Phenomenon in Acute Coronary Syndrome. Anatol J Cardiol, 27(12) : 712-9.
.2013 .(6):CD009503.. , : .
.2022 .Comparison of Intracoronary Epinephrine and Adenosine for NoReflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial). Circ Cardiovasc Interv, 15(2) : e011408.
Saood Y,Salman A,Khan M,Asim M. Comparison M .2023 .Of Intracoronary Epinephrine To Standard Treatments Alone For Refractory Coronary No-Reflow In STEMI Patients Undergoing Primary Percutaneous Coronary Intervention. Biol Clin Sci Res J, : 277.
Saif M,Amin MU,Khan HS,Maken GR,Aziz Z,Janjua AF .2020 .Comparison of intracoronary verapamil vs adenosine for restoration of coronary blood flow post percutaneous coronary intervention (PCI) in patients with no-reflow. Pak Arm Forces Med, 70(Suppl-4) : S833-37.
Nguyen LH,Drew DA,Graham MS,Joshi AD,Guo CG,Ma W .2020 .Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health, 5(9) : e475-83.
Kiani SS,Nadeem A,Chauhdry AA,Farahe A,Shafique HM,Ashraf W .2022 .Treatment of Refractory No-Reflow in Cardiac Catheterization Laboratory; Role of Intracoronary Verapamil (A Case Report). Pak Arm Forces Med, 72 : S543-6.